Executives
-
Wolk Joseph JExec VP, CFO -
Mulholland KristenEVP, Chief HR Officer
-
Decker Robert JVP Corporate Controller
-
Broadhurst VanessaEVP, Global Corp Affairs
-
Reed John CEVP, Innovative Medicine, R&D
-
Wengel Kathryn EEVP, Chief TO and Risk Officer
-
Schmid TimothyEVP, WW Chair, MedTech
-
Hait WilliamEVP, Chief EI and Med Officer
-
Swanson James D.EVP, CIO
-
Forminard ElizabethExecutive VP, General Counsel
-
Duato JoaquinCEO and Chairman of the Board
-
Fasolo PeterExec VP, Chief HR Officer
?
Wengel Kathryn E
EVP, Chief TO and Risk Officer
Johnson & Johnson
US, New Brunswick [HQ]
CIK
1745955
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
2,292
Price per Share :
$238.56
Equivalence :
$546,779.52
Transaction History
-
M2,292 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/07/24
-
Footnotes
-
-
Footnotes:#1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
-
M679,048,735 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/08/24
-
Footnotes
-
-
Footnotes:#1 Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.#2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
-
F668,958,735 Shares After TransactionValue : $104,578,319,042.55$1,577,369,700.00Transaction Date : 02/08/24
-
Footnotes
-
-
Footnotes:#1 Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.#2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
-
M1,025,338,735 Shares After TransactionValue : $92,731,635,193.40$32,231,007,200.00Transaction Date : 02/09/24
-
Footnotes
-
-
Footnotes:#1 Reflects the auto-exercise of options immediately prior to their expiration.#2 Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on the Form 4.
-
F752,008,735 Shares After TransactionValue : $117,884,889,298.60$42,847,210,800.00Transaction Date : 02/09/24
-
Footnotes
-
-
Footnotes:#1 Reflects the auto-exercise of options immediately prior to their expiration.#2 Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on the Form 4.